FOSPHENYTOIN PRESCRIBING INFORMATION PDF

This resource may include information that has not been approved by the US Food and Drug Administration. For full prescribing information, including. Fosphenytoin official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more. Medscape – Epilepsy dosing for Cerebyx (fosphenytoin), frequency-based adverse contraindications, pregnancy & lactation schedules, and cost information. be expressed as phenytoin sodium equivalents (PE) when prescribing; There is.

Author: Zulkizshura Migore
Country: Algeria
Language: English (Spanish)
Genre: Politics
Published (Last): 25 September 2004
Pages: 72
PDF File Size: 11.17 Mb
ePub File Size: 9.99 Mb
ISBN: 862-1-89796-242-7
Downloads: 24088
Price: Free* [*Free Regsitration Required]
Uploader: Guran

Fosphenytoin – DrugBank

The incidences of hepatocellular tumors were increased in female mice at all but the lowest dose tested. Data Human Data Meta-analyses using data from published observational studies and registries have estimated an ihformation 2. Pro-Epanutin may cause foetal harm when administered to a pregnant woman. Colchicine The metabolism of Colchicine can be increased when combined with Fosphenytoin.

Levopropoxyphene The therapeutic efficacy of Fosphenytoin can be decreased when used in combination with Informattion. Amoxapine The metabolism of Amoxapine can be increased when combined with Fosphenytoin.

The addition or withdrawal of phenytoin during concomitant therapy with these agents may require adjustment of the dose of these agents to achieve optimal clinical outcome.

Butaperazine The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Butaperazine. Calcitriol The metabolism of Fosphenytoin can be increased when combined prescriblng Calcitriol. Epofolate The metabolism of Fosphenytoin can be decreased when combined with Epofolate.

  GPD315 V7 PDF

Bleomycin The serum concentration of Fosphenytoin can be decreased when it is combined with Bleomycin. Iproclozide The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Iproclozide. To niformation a medicine you must sign up and log in. Dihydroergocryptine The metabolism of Fosphenytoin can be decreased when combined with Dihydroergocryptine.

Chlorphenamine The serum concentration of Fosphenytoin can be increased when it is combined with Chlorphenamine. Care should be taken to ensure the appropriate volume of CEREBYX is withdrawn from the vial when preparing the drug for administration.

Furosemide Fosphenytoin may decrease the diuretic activities of Furosemide. Aniracetam The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Aniracetam. No developmental effects were observed in offspring of pregnant rabbits given fosphenytoin; malformations have been reported in offspring of pregnant rabbits given phenytoin.

Boxes of 5 vials with 10 mL solution. Furazolidone The risk or severity of adverse effects can be increased when Furazolidone is combined with Fosphenytoin.

Dimethyltryptamine The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Dimethyltryptamine. Dolutegravir The metabolism of Dolutegravir can be decreased when combined with Fosphenytoin.

HIGHLIGHTS OF PRESCRIBING INFORMATION

Dofetilide The metabolism of Dofetilide can be increased when combined with Fosphenytoin. John’s wort may vary widely based on preparation.

Monitor unbound phenytoin concentrations in these patients 8. Other signs include tremor, hyperreflexia, lethargy, slurred speech, nausea, vomiting, coma, and hypotension. Hexobarbital The metabolism of Fosphenytoin can be decreased when combined with Hexobarbital.

  EEN SCHITTEREND GEBREK EBOOK PDF

FOSPHENYTOIN SODIUM Injection mg PE in 2ml Vial mg PE in 10 ml Vial | Mylan

Conversion could be inforrmation by alterations in the level of phosphatase activity, but given the abundance and wide fopshenytoin of phosphatases in the body it is unlikely that drugs would affect this activity enough to affect conversion of Fosphenytoin to phenytoin.

Cyproterone acetate The metabolism of Fosphenytoin can be decreased when combined with Cyproterone acetate. Fosphenytoin Sodium Injection may cause fetal harm when administered to a pregnant woman. Bexarotene The metabolism of Fosphenytoin can be increased when combined with Bexarotene.

Pro-Epanutin Concentrate for Infusion / Solution for Injection

Pro-Epanutin is therefore, contra-indicated in patients with sinus bradycardia, sino-atrial block, second and third degree A-V block and Adams-Stokes syndrome. Levofloxacin The metabolism of Fosphenytoin can be decreased when combined with Levofloxacin.

Ivermectin The metabolism of Fosphenytoin can be decreased when combined with Ivermectin. Phenytoin is not effective in absence seizures. Fluorouracil The metabolism of Fosphenytoin can be decreased when combined with Fluorouracil.